{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:02:05Z","timestamp":1775260925844,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jdmv.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T19:03:32Z","timestamp":1541012612000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Les marqueurs de thrombophilie au cours du lupus \u00e9ryth\u00e9mateux syst\u00e9mique\u00a0: une \u00e9tude cas-t\u00e9moin"],"prefix":"10.1016","volume":"43","author":[{"given":"N.","family":"Belfeki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Khanfir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Houman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2018.09.001_bib0090","first-page":"92","article-title":"Mechanisms of thrombosis in systemic lupus erythematosus","volume":"73","author":"Metoni","year":"2014","journal-title":"Roum Arch Microbiol Immunol"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0029-1242716","article-title":"Thrombosis in systemic lupus erythematosus","volume":"35","author":"Palatinus","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/art.21172","article-title":"Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors","volume":"53","author":"Afeltra","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2013.04.012","article-title":"Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study","volume":"132","author":"Zuily","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982\u00a0revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.21566","article-title":"Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus","volume":"85","author":"Mehta","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0130","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"22","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0140","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","article-title":"Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950\u00a0to 2016","volume":"76","author":"Tektonidou","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0145","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1160\/TH03-03-0151","article-title":"Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance","volume":"90","author":"Bertolaccini","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","article-title":"Association between the prevalence of antibodies to b\u00eata 2glycoprotein I, prothrombin, protein C, protein S and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications","volume":"47","author":"Nojima","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1365-2141.2002.03447.x","article-title":"Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II","volume":"117","author":"Simmelink","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.10279","article-title":"Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus","volume":"72","author":"Oh","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1191\/0961203304lu2035oa","article-title":"Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus","volume":"13","author":"Mart\u00ednez-Berriotxoa","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jdmv.2018.09.001_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.31053\/1853.0605.v62.n3.32470","article-title":"Hyperhomocystinemia as a thrombotic risk factor in patients suffering from systemic lupus erithematosus and antiphospholipid syndrome","volume":"62","author":"Onetti","year":"2005","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451318301445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451318301445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:46:31Z","timestamp":1775256391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542451318301445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2542451318301445"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2018.09.001","relation":{},"ISSN":["2542-4513"],"issn-type":[{"value":"2542-4513","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les marqueurs de thrombophilie au cours du lupus \u00e9ryth\u00e9mateux syst\u00e9mique\u00a0: une \u00e9tude cas-t\u00e9moin","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}